# Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis

> **NCT01090063** · NA · COMPLETED · sponsor: **Tufts Medical Center** · enrollment: 26 (actual)

## Conditions studied

- Moderate to Severe Palmar Plantar Psoriasis

## Interventions

- **DRUG:** Ustekinumab

## Key facts

- **NCT ID:** NCT01090063
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01090063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01090063, "Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01090063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*